Doc.com Announces Visionary Leadership Team Driving Global Healthcare Transformation
Doc.com (NASDAQ: DOCC) has announced its leadership team dedicated to developing a global healthcare platform. The company aims to transform healthcare access through AI, blockchain, and innovative technologies. The leadership team includes: Charles Nader as CEO and Founder, Neil Kleinman as CFO with over $2.25 billion in funding experience, Jamie Freed as Chief of Strategic Partnerships, Hernan Ramírez as CTO, Carlos Silis as CMO, Dr. Itzel Ocampo as Chief Science Officer, Dr. Lesly Kernisant as US Medical Director, Noemí Valencia as Chief Innovation Officer, Noel Trainor as COO, and Ignacio Valencia as Chief Business Development Officer.
The company focuses on providing free, tech-driven healthcare to underserved communities worldwide through AI-driven diagnostics and blockchain technology.
Doc.com (NASDAQ: DOCC) ha annunciato il suo team di leadership dedicato allo sviluppo di una piattaforma sanitaria globale. L'azienda mira a trasformare l'accesso alla sanità attraverso l'IA, la blockchain e tecnologie innovative. Il team di leadership include: Charles Nader come CEO e Fondatore, Neil Kleinman come CFO con oltre 2,25 miliardi di dollari di esperienza nel finanziamento, Jamie Freed come Chief of Strategic Partnerships, Hernan Ramírez come CTO, Carlos Silis come CMO, Dr. Itzel Ocampo come Chief Science Officer, Dr. Lesly Kernisant come Direttore Medico per gli Stati Uniti, Noemí Valencia come Chief Innovation Officer, Noel Trainor come COO, e Ignacio Valencia come Chief Business Development Officer.
L'azienda si concentra sull'offerta di assistenza sanitaria gratuita e tecnologicamente avanzata a comunità svantaggiate in tutto il mondo attraverso diagnosi guidate dall'IA e tecnologia blockchain.
Doc.com (NASDAQ: DOCC) ha anunciado su equipo de liderazgo dedicado al desarrollo de una plataforma de atención médica global. La empresa tiene como objetivo transformar el acceso a la atención médica a través de IA, blockchain y tecnologías innovadoras. El equipo de liderazgo incluye: Charles Nader como CEO y Fundador, Neil Kleinman como CFO con más de 2.25 mil millones de dólares en experiencia de financiamiento, Jamie Freed como Jefe de Alianzas Estratégicas, Hernan Ramírez como CTO, Carlos Silis como CMO, Dr. Itzel Ocampo como Directora de Ciencia, Dr. Lesly Kernisant como Directora Médica en EE. UU., Noemí Valencia como Directora de Innovación, Noel Trainor como COO y Ignacio Valencia como Director de Desarrollo de Negocios.
La empresa se centra en proporcionar atención médica gratuita y impulsada por tecnología a comunidades desatendidas en todo el mundo a través de diagnósticos basados en IA y tecnología blockchain.
Doc.com (NASDAQ: DOCC)는 글로벌 헬스케어 플랫폼 개발을 위한 리더십 팀을 발표했습니다. 이 회사는 AI, 블록체인 및 혁신적인 기술을 통해 헬스케어 접근 방식을 혁신하고자 합니다. 리더십 팀에는 Charles Nader가 CEO 겸 창립자로, Neil Kleinman이 CFO로서 22억 5천만 달러 이상의 자금 조달 경험을 갖고 있으며, Jamie Freed는 전략적 파트너십 책임자, Hernan Ramírez는 CTO, Carlos Silis는 CMO, Dr. Itzel Ocampo는 최고 과학 책임자, Dr. Lesly Kernisant는 미국 의료 이사, Noemí Valencia는 최고 혁신 책임자, Noel Trainor는 COO, Ignacio Valencia는 최고 사업 개발 책임자로 있습니다.
이 회사는 AI 기반 진단 및 블록체인 기술을 통해 전 세계의 소외된 지역 사회에 무료 기술 기반 헬스케어를 제공하는 데 집중하고 있습니다.
Doc.com (NASDAQ: DOCC) a annoncé son équipe de direction dédiée au développement d'une plateforme de santé mondiale. L'entreprise vise à transformer l'accès aux soins de santé grâce à l'IA, à la blockchain et à des technologies innovantes. L'équipe de direction comprend : Charles Nader en tant que PDG et fondateur, Neil Kleinman en tant que directeur financier avec plus de 2,25 milliards de dollars d'expérience en financement, Jamie Freed en tant que responsable des partenariats stratégiques, Hernan Ramírez en tant que directeur technique, Carlos Silis en tant que directeur marketing, Dr. Itzel Ocampo en tant que directeur scientifique, Dr. Lesly Kernisant en tant que directeur médical pour les États-Unis, Noemí Valencia en tant que directeur de l'innovation, Noel Trainor en tant que directeur des opérations, et Ignacio Valencia en tant que directeur du développement des affaires.
La société se concentre sur la fourniture de soins de santé gratuits et basés sur la technologie aux communautés mal desservies du monde entier grâce à des diagnostics pilotés par l'IA et à la technologie blockchain.
Doc.com (NASDAQ: DOCC) hat sein Führungsteam bekannt gegeben, das sich der Entwicklung einer globalen Gesundheitsplattform widmet. Das Unternehmen verfolgt das Ziel, den Zugang zur Gesundheitsversorgung durch KI, Blockchain und innovative Technologien zu transformieren. Das Führungsteam besteht aus: Charles Nader als CEO und Gründer, Neil Kleinman als CFO mit über 2,25 Milliarden Dollar Erfahrung in der Finanzierung, Jamie Freed als Leiter strategischer Partnerschaften, Hernan Ramírez als CTO, Carlos Silis als CMO, Dr. Itzel Ocampo als Chief Science Officer, Dr. Lesly Kernisant als medizinischer Direktor für die USA, Noemí Valencia als Chief Innovation Officer, Noel Trainor als COO und Ignacio Valencia als Chief Business Development Officer.
Das Unternehmen konzentriert sich darauf, kostenlosen, technologiegetriebenen Gesundheitsdienstleistungen an unterversorgte Gemeinschaften weltweit durch KI-gestützte Diagnosen und Blockchain-Technologie anzubieten.
- Strong leadership team with extensive industry experience
- CFO has secured over $2.25 billion in funding throughout career
- Medical Director has experience with over 500,000 patients treated
- None.
“Our leadership team reflects our unwavering commitment to transforming global healthcare,” said Charles Nader, CEO and Founder of Doc.com. “By combining innovation, technology expertise, and passion, we are breaking down barriers to care and ensuring health is no longer a privilege but a fundamental right for all.”
Meet Doc.com’s Leadership Team:
Charles Nader, Chief Executive Officer
Founder and CEO of Doc.com, Charles Nader is dedicated to making healthcare universally accessible. With a background in medicine and a student of blitzscaling at Stanford ,Charles has leveraged AI and blockchain to revolutionize global healthcare. Under his leadership, Doc.com is expanding its mission to provide free, tech-driven care to underserved communities worldwide.
Neil Kleinman, Chief Financial Officer
Neil Kleinman brings over 30 years of financial expertise to Doc.com, with a career marked by securing over
Jamie Freed, Chief of Strategic Partnerships
Jamie Freed is a renowned expert in entertainment, marketing, and strategic partnerships, with a proven track record of building high-profile brands. As the driving force behind the early discovery and management of Selena Gomez, Jamie played a pivotal role in launching her ascent to billion-dollar status. He also accelerated Paris Hilton’s empire, transforming her into a global brand powerhouse. At Doc.com, Jamie leverages his expertise to lead brand development, media strategies, and strategic collaborations, advancing the company’s mission of delivering accessible, tech-driven healthcare to a global audience.
Hernan Ramírez, Chief Technology Officer
With 20 years of experience in innovative tech solutions, Hernan Ramírez oversees the development of Doc.com’s AI-powered telemedicine platform. His expertise developing award winning technology is central to delivering secure, accessible healthcare to underserved populations.
Carlos Silis, Chief Marketing Officer
Carlos Silis, a digital marketing leader with over 20 years of experience, drives Doc.com’s global marketing efforts. He leverages AI to increase awareness of the company’s mission to provide equitable, tech-enabled healthcare worldwide.
Itzel Ocampo, MD, Chief Science Officer
Dr. Itzel Ocampo brings over a decade of experience in e-health and surgery to her role as Chief Science Officer. She ensures Doc.com’s healthcare solutions meet the highest medical standards, advancing telemedicine and AI-driven diagnostics, and developing new tools to maximize healthcare.
Lesly Kernisant, MD, Medical Director, US
With 20+ years of experience and over 500,000 patients treated, Dr. Lesly Kernisant leads Doc.com’s
Noemí
Noemí
Noel Trainor, Chief Operations Officer
With 30+ years in healthcare and education operations, Noel Trainor ensures Doc.com’s services are efficient, scalable, and impactful. His leadership enhances the delivery of accessible healthcare to underserved populations.
Ignacio Valencia, Chief Business Development Officer
Ignacio Valencia, with nearly 30 years of experience in partnerships and growth, leads global business development at Doc.com. His expertise in strategic relationships working in fortune 500 companies expands the company’s reach, delivering affordable healthcare solutions worldwide.
Under the leadership of this distinguished team, Doc.com is advancing the development of an integrated global healthcare ecosystem. By leveraging AI-driven diagnostics, blockchain technology, and innovative solutions, Doc.com is breaking down barriers to care and providing free, accessible healthcare services to underserved communities. In addition, the company is optimizing hospital systems and accelerating drug development, ensuring that healthcare is not a privilege, but a fundamental human right for all. With a strong commitment to global expansion, Doc.com is shaping the future of healthcare, empowering individuals and communities worldwide with the tools they need to take control of their well-being.
About Doc.com, Inc.
We deliver a global, optimized ecosystem that supports physical, emotional, and educational needs by leveraging innovation, AI-driven diagnostics, and blockchain transparency.
Cautionary Note Regarding Forward Looking Statements
Certain information set forth in this presentation contains “forward-looking information”, including “future-oriented financial information” and “financial outlook”, under applicable securities laws (collectively referred to herein as forward-looking statements). Except for statements of historical fact, the information contained herein constitutes forward-looking statements and includes, but is not limited to, the (i) projected financial performance of the Company; (ii) completion of, and the use of proceeds from, the sale of the shares being offered hereunder; (iii) the expected development of the Company’s business, projects, and joint ventures; (iv) execution of the Company’s vision and growth strategy, including with respect to future M&A activity and global growth; (v) sources and availability of third-party financing for the Company’s projects; (vi) completion of the Company’s projects that are currently underway, in development or otherwise under consideration; (vi) renewal of the Company’s current customer, supplier and other material agreements; and (vii) future liquidity, working capital, and capital requirements. Forward-looking statements are provided to allow potential investors the opportunity to understand management’s beliefs and opinions in respect of the future so that they may use such beliefs and opinions as one factor in evaluating an investment.
These statements are not guarantees of future performance and undue reliance should not be placed on them. Such forward-looking statements necessarily involve known and unknown risks and uncertainties, which may cause actual performance and financial results in future periods to differ materially from any projections of future performance or result expressed or implied by such forward-looking statements. Although forward-looking statements contained in this presentation are based upon what management of the Company believes are reasonable assumptions, there can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. The Company undertakes no obligation to update forward-looking statements if circumstances or management’s estimates or opinions should change except as required by applicable securities laws. The reader is cautioned not to place undue reliance on forward-looking statements.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250211989272/en/
For more corporate information please visit: doc.com
For further information, please contact: Tiffany Cummins
Email: tiffany.cummins@talentresources.com
Business Tel: 925-212-4200
Source: Doc.com, Inc.
FAQ
What is Doc.com (DOCC) primary mission in healthcare technology?
How much funding experience does Doc.com's CFO Neil Kleinman bring to the company?
What is the background of Doc.com's CEO Charles Nader?
How many patients has Doc.com's US Medical Director Dr. Lesly Kernisant treated?
What technologies does Doc.com (DOCC) use to deliver healthcare services?
